Astera Labs, Inc. saw its shares plummet 5.03% during pre-market trading on Monday, as the stock faced significant selling pressure.

The decline follows a rating downgrade from Northland Capital Markets, which moved Astera Labs from Outperform to Market Perform, citing elevated valuation and growing concerns that hyperscale cloud providers may cut AI infrastructure spending in 2027. Additionally, concentrated insider selling has reinforced market concerns about overvaluation, with the company's President and COO recently selling approximately 399,000 shares and a trust associated with a former executive planning to sell an additional 30,000 shares.

Analyst consensus target price stands significantly below the current share price, underscoring persistent valuation pressure that has kept shares under sustained pressure despite prior positive catalysts.